Analyst consensus rating
Biohaven Analyst Rating: Buy
Direct answer
Biohaven's consensus rating is Buy.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $21.73.
Forecast evidence checked September 8, 2026.
Get free Biohaven email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.72
- Average price target
- $21.73
- High price target
- $42.00
- Low price target
- $10.00
- Low target gap
- -32.1%
- Target upside
- +47.6%
- High target gap
- +185.3%
- Target range width
- 217.4%
- Consensus rating
- Buy
- Analysts
- 15
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Biohaven?
Biohaven has a verified Buy consensus. The same dataset has an average price target of $21.73.
How far are Biohaven's low and high targets from the recorded price?
The low target implies -32.1%, while the high target implies +185.3%.
How many analysts are included in Biohaven's consensus?
The verified consensus includes 15 analysts.
How is Biohaven's target upside or downside calculated?
The average target of $21.73 is divided by the recorded price of $14.72, then one is subtracted to produce +47.6%. This does not guarantee a future return.
When was Biohaven's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.